| Year |
Citation |
Score |
| 2018 |
Al-Bawardy B, Ramos GP, Willrich MAV, Jenkins SM, Park SH, Aniwan S, Schoenoff SA, Bruining DH, Papadakis KA, Raffals L, Tremaine WJ, Loftus EV. Vedolizumab Drug Level Correlation With Clinical Remission, Biomarker Normalization, and Mucosal Healing in Inflammatory Bowel Disease. Inflammatory Bowel Diseases. PMID 30165638 DOI: 10.1093/Ibd/Izy272 |
0.313 |
|
| 2018 |
Hansel SL, McCurdy JD, Barlow JM, Fidler J, Fletcher JG, Becker B, Prabhu NC, Faubion WA, Hanson KA, Kane SV, Kisiel JB, Loftus EV, Papadakis KA, Pardi DS, Raffals LE, et al. Clinical Benefit of Capsule Endoscopy in Crohn's Disease: Impact on Patient Management and Prevalence of Proximal Small Bowel Involvement. Inflammatory Bowel Diseases. PMID 29788055 DOI: 10.1093/Ibd/Izy050 |
0.311 |
|
| 2017 |
Ramos GP, Faubion WA, Papadakis KA. Targeting Specific Immunologic Pathways in Crohn's Disease. Gastroenterology Clinics of North America. 46: 577-588. PMID 28838416 DOI: 10.1016/J.Gtc.2017.05.009 |
0.316 |
|
| 2017 |
Tse CS, Deepak P, De La Fuente J, Murray J, Papadakis K. P616 Natural history and phenotype of inflammatory bowel disease with co-existent celiac disease. Journal of Crohn's & Colitis. 11: S394-S395. PMID 28172727 DOI: 10.1093/Ecco-Jcc/Jjx002.740 |
0.332 |
|
| 2016 |
Sarmento OF, Svingen PA, Xiong Y, Sun Z, Bamidele AO, Mathison AJ, Smyrk TC, Nair AA, Gonzalez MM, Sagstetter MR, Baheti S, McGovern DP, Friton JJ, Papadakis KA, Gautam G, et al. The Role of the Histone Methyltransferase Enhancer of Zeste Homolog 2 (EZH2) in the Pathobiological Mechanisms Underlying Inflammatory Bowel Disease (IBD). The Journal of Biological Chemistry. PMID 27909059 DOI: 10.1074/Jbc.M116.749663 |
0.322 |
|
| 2016 |
Sarmento O, Xiong Y, Sun Z, Svingen P, Bamidele A, Smyrk T, Nair A, Baheti S, McGovern D, Friton J, Papadakis K, Goel G, Xavier R, Urrutia R, Faubion W. O-015 YI Alterations in the FOXP3-EZH2 Pathway Associates with Increased Susceptibility to Colitis in Both Mice and Human. Inflammatory Bowel Diseases. 22: S5-S6. PMID 26849732 DOI: 10.1097/01.Mib.0000480101.02647.09 |
0.353 |
|
| 2013 |
Arranz A, Reinsch C, Papadakis K, Dieckmann A, Rauchhaus U, Androulidaki A, Zacharioudaki V, Margioris AN, Tsatsanis C, Panzner S. Treatment of experimental murine colitis with CD40 antisense oligonucleotides delivered in amphoteric liposomes. Journal of Controlled Release. 165: 163-172. PMID 23178664 DOI: 10.1016/J.Jconrel.2012.11.008 |
0.318 |
|
| 2008 |
Kwan LY, Devlin SM, Mirocha JM, Papadakis KA. Thiopurine methyltransferase activity combined with 6-thioguanine metabolite levels predicts clinical response to thiopurines in patients with inflammatory bowel disease. Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association For the Study of the Liver. 40: 425-32. PMID 18304898 DOI: 10.1016/J.Dld.2008.01.003 |
0.306 |
|
| 2003 |
Mow W, Vasiliauskas EA, Lin Y, Fleshner PR, Papadakis K, Taylor KD, Landers CJ, Rotter JI, Abreu MT, Yang H, Targan SR. Antibodies against the Crohn's disease (CD)-associated bacterial sequence 12 (anti-12) are an independent marker of fibrostenosing CD Gastroenterology. 124: A2. DOI: 10.1016/S0016-5085(03)80009-4 |
0.304 |
|
| Show low-probability matches. |